Correlation Between Seres Therapeutics and Exicure
Can any of the company-specific risk be diversified away by investing in both Seres Therapeutics and Exicure at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Seres Therapeutics and Exicure into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Seres Therapeutics and Exicure, you can compare the effects of market volatilities on Seres Therapeutics and Exicure and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Seres Therapeutics with a short position of Exicure. Check out your portfolio center. Please also check ongoing floating volatility patterns of Seres Therapeutics and Exicure.
Diversification Opportunities for Seres Therapeutics and Exicure
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Seres and Exicure is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Seres Therapeutics and Exicure in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exicure and Seres Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Seres Therapeutics are associated (or correlated) with Exicure. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exicure has no effect on the direction of Seres Therapeutics i.e., Seres Therapeutics and Exicure go up and down completely randomly.
Pair Corralation between Seres Therapeutics and Exicure
Given the investment horizon of 90 days Seres Therapeutics is expected to generate 12.27 times less return on investment than Exicure. But when comparing it to its historical volatility, Seres Therapeutics is 3.42 times less risky than Exicure. It trades about 0.14 of its potential returns per unit of risk. Exicure is currently generating about 0.5 of returns per unit of risk over similar time horizon. If you would invest 303.00 in Exicure on September 1, 2024 and sell it today you would earn a total of 2,646 from holding Exicure or generate 873.27% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Seres Therapeutics vs. Exicure
Performance |
| Timeline |
| Seres Therapeutics |
| Exicure |
Seres Therapeutics and Exicure Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Seres Therapeutics and Exicure
The main advantage of trading using opposite Seres Therapeutics and Exicure positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Seres Therapeutics position performs unexpectedly, Exicure can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exicure will offset losses from the drop in Exicure's long position.| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
| Exicure vs. Ikena Oncology | Exicure vs. Eliem Therapeutics | Exicure vs. HCW Biologics | Exicure vs. RenovoRx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |